Impact of Rituximab on COVID-19 in Immunocompromised Patients: A Nationwide Cohort Study in Korea - Poll - MDSpire

Impact of Rituximab on COVID-19 in Immunocompromised Patients: A Nationwide Cohort Study in Korea

  • By

  • Chan Mi Lee

  • Suhyun Kim

  • Hyeon Jae Jo

  • Chang Kyung Kang

  • Wan Beom Park

  • Nam Joong Kim

  • Seungyeon Kim

  • Pyoeng Gyun Choe

  • April 29, 2025

  • 0 min

Share

Original Source(s)

Impact of Rituximab on COVID-19 in Immunocompromised Patients: A Nationwide Cohort Study in Korea

  • by Chan Mi Lee, Suhyun Kim, Hyeon Jae Jo, Chang Kyung Kang, Wan Beom Park, Nam Joong Kim, Seungyeon Kim, Pyoeng Gyun Choe

  • April 29, 2025

Related Content

Nirsevimab and a Community Recall-Based Immunization Strategy for Child Bronchiolitis Prevention

Serum cytokine profiling reveals CXCL10 (IP-10) as a major predictor of severe COVID-19 outcomes in hospitalized patients during the first pandemic wave in Italy

MEK1/2 inhibitor ATR-002 reshapes host transcriptome and modulates immune regulatory genes in SARS-CoV-2 infection